You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 13, 12 JULY 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Preventing Restenosis With Fish Oils Following Coronary Angioplasty

A Meta-analysis

James P. Gapinski, MD; Jerome V. VanRuiswyk, MD, MS; Gustavo R. Heudebert, MD; Gordon S. Schectman, MD

Arch Intern Med. 1993;153(13):1595-1601.


Abstract

Backround
No medical therapy has been shown to reduce the rate of restenosis following percutaneous transluminal coronary angioplasty. We examined the existing evidence for the use of omega-3 fatty acids in this capacity with the tool of meta-analysis.

Methods
A computerized search and a bibliographic review of published articles were performed. Abstracts were identified through journals, Index Medicus, and an unpublished listing of recent requests for fish oil for experimental use. All English-language randomized clinical trials with available reports were included in the analysis. The quality, design differences, and outcomes were evaluated for each study.

Results
For four studies that used angiography to define coronary restenosis, the absolute difference in restenosis rates between treatment and control groups was 13.9% (95% confidence interval [CI], 3.2% to 24.5%). Furthermore, regression analysis revealed a positive linear relationship between the dose of omega-3 fatty acids used and the absolute difference in restenosis rates (r=.99, P<.03). When three studies that used stress testing as a means of determining restenosis rates were added to the four studies that used angiography, the risk difference was 5.1% (95% CI, —3.8% to 13.9%).

Conclusions
Restenosis after coronary angioplasty is reduced by supplemental fish oils, and the extent of the observed benefit may be dependent on the dose of omega-3 fatty acids used.

(Arch Intern Med. 1993;153:1595-1601)



Author Affiliations

From the Division of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, Zablocki Veterans Affairs Medical Center, Milwaukee.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Are dietary recommendations for the use of fish oils sustainable?
Jenkins et al.
CMAJ 2009;180:633-637.
FULL TEXT  

Omega-3 fatty acids: a comprehensive review of their role in health and disease
Yashodhara et al.
Postgrad. Med. J. 2009;85:84-90.
ABSTRACT | FULL TEXT  

Heterogeneity in Randomized Controlled Trials of Long Chain (Fish) Omega-3 Fatty Acids in Restenosis, Secondary Prevention and Ventricular Arrhythmias
Jenkins et al.
J. Am. Coll. Nutr. 2008;27:367-378.
ABSTRACT | FULL TEXT  

Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine)
Vogel et al.
J Am Coll Cardiol 2005;46:184-221.
FULL TEXT  

Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:e20-30.
FULL TEXT  

Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton et al.
Circulation 2002;106:2747-2757.
FULL TEXT  

New Zealand and United Kingdom experiences with the RAND modified Delphi approach to producing angina and heart failure criteria for quality assessment in general practice
Buetow and Coster
Qual Saf Health Care 2000;9:222-231.
ABSTRACT | FULL TEXT  

n-3 Fatty acids and the prevention of coronary atherosclerosis1
von Schacky
Am. J. Clin. Nutr. 2000;71:224S-227S.
ABSTRACT | FULL TEXT  

Essential fatty acids in health and chronic disease
Simopoulos
Am. J. Clin. Nutr. 1999;70:560S-569.
ABSTRACT | FULL TEXT  

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
Gibbons et al.
J Am Coll Cardiol 1999;33:2092-2197.
FULL TEXT  

n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study
Johansen et al.
J Am Coll Cardiol 1999;33:1619-1626.
ABSTRACT | FULL TEXT  

Perspectives in the Treatment of Dyslipidemias in the Prevention of Coronary Heart Disease
Borgia and Medici
ANGIOLOGY 1998;49:339-348.
ABSTRACT  

Fish Intake May Limit the Increase in Risk of Coronary Heart Disease Morbidity and Mortality Among Heavy Smokers: The Honolulu Heart Program
Rodriguez et al.
Circulation 1996;94:952-956.
ABSTRACT | FULL TEXT  

Fish oils and cardiovascular disease
Prichard et al.
BMJ 1995;310:819-820.
FULL TEXT  

Patient-Directed, Nonprescription Approaches to Cardiovascular Disease
Simon
Arch Intern Med 1994;154:2283-2296.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.